Holdings (Monthly)
Guide ↗
Pharmaceuticals Ultrasector Profund
· ProFunds| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | N/A | N/A | Jan 2026 | 221,000 | $221K | 5.84% | RA |
| 2 | N/A | N/A | Jan 2026 | 177,000 | $177K | 4.68% | RA |
| 3 | N/A | N/A | Jan 2026 | 170,000 | $170K | 4.49% | RA |
| 4 | N/A | N/A | Jan 2026 | 101,000 | $101K | 2.67% | RA |
| 5 | N/A | N/A | Jan 2026 | 94,000 | $94K | 2.48% | RA |
| 6 | Definium Therapeutics Inc. | 24477V105 | Jan 2026 | 4,664 | $79K | 2.08% | EC |
| 7 | Liquidia Corporation | 53635D202 | Jan 2026 | 1,767 | $75K | 1.98% | EC |
| 8 | MBX Biosciences, Inc. | 55287L101 | Jan 2026 | 2,003 | $74K | 1.95% | EC |
| 9 | Axsome Therapeutics Inc. | 05464T104 | Jan 2026 | 387 | $71K | 1.88% | EC |
| 10 | Organon & Co | 68622V106 | Jan 2026 | 8,042 | $69K | 1.82% | EC |
| 11 | Edgewise Therapeutics Inc. | 28036F105 | Jan 2026 | 2,432 | $68K | 1.81% | EC |
| 12 | Elanco Animal Health Inc | 28414H103 | Jan 2026 | 2,711 | $65K | 1.73% | EC |
| 13 | Merck & Co., Inc | 58933Y105 | Jan 2026 | 591 | $65K | 1.72% | EC |
| 14 | Viatris Inc | 92556V106 | Jan 2026 | 4,977 | $65K | 1.72% | EC |
| 15 | Amneal Pharmaceuticals Inc | 03168L105 | Jan 2026 | 4,729 | $65K | 1.71% | EC |
| 16 | Johnson & Johnson | 478160104 | Jan 2026 | 280 | $64K | 1.68% | EC |
| 17 | Royalty Pharma PLC | G7709Q104 | Jan 2026 | 1,509 | $63K | 1.66% | EC |
| 18 | Amylyx Pharmaceuticals Inc | 03237H101 | Jan 2026 | 4,364 | $62K | 1.65% | EC |
| 19 | Bristol-Myers Squibb Company | 110122108 | Jan 2026 | 1,127 | $62K | 1.64% | EC |
| 20 | Xeris Biopharma Holdings Inc | 98422E103 | Jan 2026 | 8,320 | $61K | 1.62% | EC |
| 21 | Zoetis Inc. | 98978V103 | Jan 2026 | 489 | $61K | 1.61% | EC |
| 22 | Perrigo Company PLC | G97822103 | Jan 2026 | 4,271 | $61K | 1.60% | EC |
| 23 | Prestige Consumer Healthcare Inc | 74112D101 | Jan 2026 | 941 | $61K | 1.60% | EC |
| 24 | Ligand Pharmaceuticals Incorporated | 53220K504 | Jan 2026 | 314 | $60K | 1.59% | EC |
| 25 | Supernus Pharmaceuticals, Inc | 868459108 | Jan 2026 | 1,251 | $60K | 1.59% | EC |
| 26 | Eli Lilly & Co. | 532457108 | Jan 2026 | 58 | $60K | 1.59% | EC |
| 27 | Crinetics Pharmaceuticals Inc. | 22663K107 | Jan 2026 | 1,201 | $60K | 1.59% | EC |
| 28 | Pfizer Inc. | 717081103 | Jan 2026 | 2,240 | $59K | 1.57% | EC |
| 29 | Arvinas Inc | 04335A105 | Jan 2026 | 4,362 | $58K | 1.54% | EC |
| 30 | Avadel Pharmaceuticals PLC | G29687103 | Jan 2026 | 2,688 | $58K | 1.53% | EC |
| 31 | Indivior Pharmaceuticals Inc. | 45579U109 | Jan 2026 | 1,629 | $58K | 1.52% | EC |
| 32 | ANI Pharmaceuticals Inc. | 00182C103 | Jan 2026 | 704 | $58K | 1.52% | EC |
| 33 | Enliven Therapeutics Inc | 29337E102 | Jan 2026 | 2,178 | $58K | 1.52% | EC |
| 34 | Jazz Pharmaceuticals PLC | G50871105 | Jan 2026 | 350 | $58K | 1.52% | EC |
| 35 | Maze Therapeutics Inc | 578784100 | Jan 2026 | 1,295 | $56K | 1.49% | EC |
| 36 | Innoviva Inc | 45781M101 | Jan 2026 | 2,800 | $56K | 1.48% | EC |
| 37 | Collegium Pharmaceutical Inc. | 19459J104 | Jan 2026 | 1,182 | $54K | 1.43% | EC |
| 38 | Phibro Animal Health Corporation | 71742Q106 | Jan 2026 | 1,343 | $54K | 1.43% | EC |
| 39 | Harmony Biosciences Holdings Inc | 413197104 | Jan 2026 | 1,470 | $54K | 1.42% | EC |
| 40 | Rapport Therapeutics Inc | 75383L102 | Jan 2026 | 1,926 | $51K | 1.35% | EC |
| 41 | Esperion Therapeutics Inc | 29664W105 | Jan 2026 | 15,075 | $51K | 1.35% | EC |
| 42 | Amphastar Pharmaceuticals Inc | 03209R103 | Jan 2026 | 1,897 | $50K | 1.33% | EC |
| 43 | Pacira Biosciences Inc | 695127100 | Jan 2026 | 2,293 | $47K | 1.24% | EC |
| 44 | Harrow Inc | 415858109 | Jan 2026 | 1,150 | $47K | 1.24% | EC |
| 45 | Ventyx Biosciences Inc. | 92332V107 | Jan 2026 | 3,368 | $47K | 1.24% | EC |
| 46 | Phathom Pharmaceuticals Inc | 71722W107 | Jan 2026 | 3,421 | $47K | 1.24% | EC |
| 47 | Eyepoint Inc. | 30233G209 | Jan 2026 | 3,453 | $47K | 1.23% | EC |
| 48 | Tarsus Pharmaceuticals Inc | 87650L103 | Jan 2026 | 710 | $46K | 1.21% | EC |
| 49 | Terns Pharmaceuticals Inc. | 880881107 | Jan 2026 | 1,294 | $45K | 1.18% | EC |
| 50 | Trevi Therapeutics Inc | 89532M101 | Jan 2026 | 4,075 | $43K | 1.13% | EC |
| 51 | Nuvation Bio Inc | 67080N101 | Jan 2026 | 7,365 | $39K | 1.02% | EC |
| 52 | Nektar Therapeutics | 640268306 | Jan 2026 | 1,000 | $37K | 0.99% | EC |
| 53 | Wave Life Sciences Ltd. | Y95308105 | Jan 2026 | 2,854 | $37K | 0.98% | EC |
| 54 | Zevra Therapeutics Inc | 488445206 | Jan 2026 | 3,932 | $35K | 0.94% | EC |
| 55 | Omeros Corp | 682143102 | Jan 2026 | 3,019 | $35K | 0.93% | EC |
| 56 | AGPXX | 825252885 | Jan 2026 | 34,370 | $34K | 0.91% | STIV |
| 57 | Ocular Therapeutix Inc | 67576A100 | Jan 2026 | 3,750 | $34K | 0.91% | EC |
| 58 | CorMedix Inc. | 21900C308 | Jan 2026 | 4,387 | $34K | 0.90% | EC |
| 59 | Lenz Therapeutics Inc | 52635N103 | Jan 2026 | 1,869 | $30K | 0.78% | EC |
| 60 | Corcept Therapeutics Inc. | 218352102 | Jan 2026 | 677 | $27K | 0.71% | EC |
| 61 | Theravance Biopharma Inc | G8807B106 | Jan 2026 | 1,409 | $27K | 0.71% | EC |
| 62 | Alumis Inc | 022307102 | Jan 2026 | 1,017 | $25K | 0.66% | EC |
| 63 | Septerna Inc. | 81734D104 | Jan 2026 | 1,042 | $24K | 0.64% | EC |
| 64 | Evolus Inc | 30052C107 | Jan 2026 | 4,490 | $21K | 0.56% | EC |
| 65 | Aquestive Therapeutics Inc | 03843E104 | Jan 2026 | 6,279 | $19K | 0.49% | EC |
| 66 | N/A | N/A | Jan 2026 | -106 | $7K | 0.19% | DE |
| 67 | N/A | N/A | Jan 2026 | 211 | $-19953 | -0.53% | DE |
| 68 | N/A | N/A | Jan 2026 | 335 | $-36686 | -0.97% | DE |